| scholarly article | Q13442814 |
| P2093 | author name string | Yang H | |
| Liuzzo G | |||
| Frye RL | |||
| Weyand CM | |||
| Holmes DR | |||
| Goronzy JJ | |||
| Kopecky SL | |||
| P433 | issue | 25 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2883-2888 | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes | |
| P478 | volume | 101 |
| Q43294835 | 'Hot stuff': inflammatory lymphocyte populations in acute coronary syndrome |
| Q36290168 | 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus |
| Q38962768 | A Proinflammatory Secretome Mediates the Impaired Immunopotency of Human Mesenchymal Stromal Cells in Elderly Patients with Atherosclerosis |
| Q41784100 | A human-mouse chimeric model of obliterative bronchiolitis after lung transplantation |
| Q36746012 | Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions |
| Q34601733 | Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? |
| Q57226743 | Activating NK-cell receptors co-stimulate CD4+CD28−T cells in patients with rheumatoid arthritis |
| Q47782268 | Acute Coronary Syndromes: The Way Forward From Mechanisms to Precision Treatment |
| Q30241848 | Adaptive Immunity Dysregulation in Acute Coronary Syndromes: From Cellular and Molecular Basis to Clinical Implications |
| Q36914125 | Adaptive immunity, inflammation, and cardiovascular complications in type 1 and type 2 diabetes mellitus |
| Q40398975 | Aging of the Immune System. Mechanisms and Therapeutic Targets |
| Q24797866 | Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation |
| Q47601365 | Alterations in peripheral blood lymphocyte cytokine expression in obesity. |
| Q50774005 | Altered CD31 expression and activity in helper T cells of acute coronary syndrome patients. |
| Q33996111 | Altered mitochondrial membrane potential, mass, and morphology in the mononuclear cells of humans with type 2 diabetes |
| Q33365736 | Antibodies to platelet factor 4/heparin are associated with elevated endothelial cell activation markers in patients with acute coronary ischemic syndromes |
| Q34221820 | Apoptotic effects of antilymphocyte globulins on human pro-inflammatory CD4+CD28- T-cells |
| Q54411384 | Association between HLA-DRB1, HLA-DRQB1 alleles, and CD4+CD28null T cells in a Chinese population with coronary heart disease |
| Q36403294 | Association of Elevations of Specific T Cell and Monocyte Subpopulations in Rheumatoid Arthritis With Subclinical Coronary Artery Atherosclerosis |
| Q54584367 | Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis. |
| Q34401259 | Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis |
| Q79978197 | Asymptomatic kindred of patients with coronary events have increased peripheral T-cell activities |
| Q58492104 | Atherogenesis and Inflammation |
| Q44068950 | Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. |
| Q42005918 | Atorvastatin inhibits the immediate-early response gene EGR1 and improves the functional profile of CD4+T-lymphocytes in acute coronary syndromes |
| Q90228512 | Autoantibodies for Cardiac Channels and Sudden Cardiac Death and its Relationship to Autoimmune Disorders |
| Q92104941 | Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis |
| Q47759701 | Autoreactive antibody repertoire is perturbed in atherosclerotic patients. |
| Q40010707 | Beta2-integrin activation on T cell subsets is an independent prognostic factor in unstable angina pectoris |
| Q34369787 | C-Reactive Protein and secondary prevention of coronary events. |
| Q36915514 | CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients |
| Q33529016 | CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis |
| Q58796708 | CD28 pro-atherogenic CD4 T-cells explain the link between CMV infection and an increased risk of cardiovascular death |
| Q42726164 | CD4+ T cells, human cytomegalovirus and end-stage renal disease |
| Q40373160 | CD4+CD28null T Cells are related to previous cytomegalovirus infection but not to accelerated atherosclerosis in ANCA-associated vasculitis |
| Q55511972 | CD4+CD28null T Lymphocytes are Associated with the Development of Atrial Fibrillation after Elective Cardiac Surgery. |
| Q46173776 | CD4+CD28null T cells in acute coronary syndrome: lower with ST-elevation myocardial infarction. |
| Q48177039 | Can we talk about CD4+CD28- lymphocytes as a risk factor for ischemic stroke? |
| Q36835851 | Cardiovascular co-morbidity in rheumatic diseases |
| Q33943374 | Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment |
| Q43061600 | Cardiovascular disease complications in systemic lupus erythematosus |
| Q37956137 | Cardiovascular safety of biologic therapies for the treatment of RA. |
| Q60911885 | Characteristics of T cell receptor repertoires of patients with acute myocardial infarction through high-throughput sequencing |
| Q51889875 | Characteristics of expanded CD4+CD28null T cells in patients with chronic hepatitis B. |
| Q35833640 | Characterization of CD8(+)CD57(+) T cells in patients with acute myocardial infarction |
| Q43711233 | Circulating CD4(+)CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation. |
| Q50982075 | Circulating CD4+CD28null and extra-thymic CD4+CD8+ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients. |
| Q35091286 | Circulating activated and effector memory T cells are associated with calcification and clonal expansions in bicuspid and tricuspid valves of calcific aortic stenosis |
| Q54790703 | Clinical significance of increased peripheral blood CD4(+) CD28(-) T cells of asthmatic children. |
| Q35558887 | Clonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes |
| Q43245985 | Combination of peroxisome proliferator-activated receptor α/γ agonists may benefit type 2 diabetes patients with coronary artery disease through inhibition of inflammatory cytokine secretion |
| Q38290992 | Contribution of neovascularization and intraplaque haemorrhage to atherosclerotic plaque progression and instability |
| Q42120717 | Cytomegalovirus-induced effector T cells cause endothelial cell damage. |
| Q57371365 | Cytotoxic CD4 + CD28 null T Lymphocytes, Systemic Inflammation and Atherosclerotic Risk in Patients with Chronic Kidney Disease |
| Q39283173 | Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges |
| Q43907857 | Death-inducing receptors and apoptotic changes in lymphocytes of patients with heart transplant vasculopathy |
| Q33571198 | Decreased ERK and JNK signaling contribute to gene overexpression in "senescent" CD4+CD28- T cells through epigenetic mechanisms |
| Q47094217 | Deep sequencing of the T cell receptor β repertoire reveals signature patterns and clonal drift in atherosclerotic plaques and patients |
| Q33646411 | Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis |
| Q38053067 | Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology |
| Q49519207 | Dichotomous roles of co-stimulatory molecules in diabetes mellitus. |
| Q30881300 | Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa |
| Q42523367 | Effect of coronary percutaneous revascularization on interferon-gamma and interleukin-10 producing CD4+ T cells during acute myocardial infarction |
| Q42931550 | Effect of oral sirolimus therapy on inflammatory biomarkers following coronary stenting |
| Q36366126 | Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal Models |
| Q36758692 | Effects of conventional immunosuppressive treatment on CD244+ (CD28null) and FOXP3+ T cells in the inflamed muscle of patients with polymyositis and dermatomyositis |
| Q50976939 | Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial. |
| Q35636932 | Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome |
| Q46492456 | Expansion of cytolytic CD4+CD28- T cells in end-stage renal disease |
| Q37675607 | Expansions of Cytotoxic CD4+CD28- T Cells Drive Excess Cardiovascular Mortality in Rheumatoid Arthritis and Other Chronic Inflammatory Conditions and Are Triggered by CMV Infection |
| Q30654017 | Expression of calpain-calpastatin system (CCS) member proteins in human lymphocytes of young and elderly individuals; pilot baseline data for the CALPACENT project |
| Q58295565 | Functional T‐lymphocyte dichotomy in the peripheral blood of patients with unstable angina |
| Q37054959 | Functional role of peripheral opioid receptors in the regulation of cardiac spinal afferent nerve activity during myocardial ischemia |
| Q35915210 | Genetics of rheumatoid arthritis: Is there a pattern predicting extraarticular manifestations? |
| Q44524615 | Glutathione S-transferase M1, T1, and P1 gene polymorphisms and carotid atherosclerosis in Korean patients with rheumatoid arthritis |
| Q64105803 | HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke |
| Q37379921 | Heat shock proteins 60 and 70 specific proinflammatory and cytotoxic response of CD4+CD28null cells in chronic kidney disease |
| Q38962508 | Immune Cells in Cardiovascular Disease: Has the Time Arrived for New Targets in Human Hypertension? |
| Q34777989 | Immune aging and autoimmunity |
| Q34036703 | Immune aging and rheumatoid arthritis |
| Q38985096 | Immune-inflammatory Activation in Acute Coronary Syndromes: A Look into the Heart of Unstable Coronary Plaque. |
| Q35198258 | Immunosenescence, autoimmunity, and rheumatoid arthritis |
| Q34712199 | Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations |
| Q55666115 | Increased Soluble CD137 Levels and CD4+ T-Cell-Associated Expression of CD137 in Acute Atherothrombotic Stroke. |
| Q35554431 | Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study |
| Q59710241 | Increased production of inflammatory cytokines in patients with silent myocardial ischemia |
| Q49254089 | Indoleamine 2,3-Dioxygenase (IDO) Enzyme Links Innate Immunity and Altered T-Cell Differentiation in Non-ST Segment Elevation Acute Coronary Syndrome. |
| Q58177938 | Inflammation and immune response in acute aortic dissection |
| Q38083555 | Inflammation and immune system interactions in atherosclerosis |
| Q26827525 | Inflammation, immunity, and hypertensive end-organ damage |
| Q38788685 | Inflammatory processes in cardiovascular disease: a route to targeted therapies |
| Q33811114 | Insufficient deactivation of the protein tyrosine kinase lck amplifies T-cell responsiveness in acute coronary syndrome |
| Q34520320 | Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. |
| Q42866736 | Intestinal Angina Due to Atherosclerosis in a 45-year-old Systemic Lupus Erythematosus Patient |
| Q26746659 | Is the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritis |
| Q53674067 | Killer cell immunoglobulin receptor profile on CD4(+) CD28(-) T cells and their pathogenic role in non-dialysis-dependent and dialysis-dependent chronic kidney disease patients. |
| Q33561481 | Leukocyte Trafficking in Cardiovascular Disease: Insights from Experimental Models |
| Q35609394 | Levels of serum IL-1beta, IL-2, IL-8 and tumor necrosis factor-alpha in patients with unstable angina pectoris. |
| Q46199434 | Light-dark variations in neopterin serum levels in patients with ST-segment elevation acute coronary syndrome undergoing primary angioplasty. |
| Q53341641 | Liver X receptor agonist prevents the evolution of collagen-induced arthritis in mice. |
| Q47738428 | Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea |
| Q36339037 | Lymphocyte subpopulations in myocardial infarction: a comparison between peripheral and intracoronary blood |
| Q36368995 | Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis |
| Q37428743 | Management of cardiovascular disease risk in chronic inflammatory disorders |
| Q92668029 | Mechanisms underlying T cell ageing |
| Q50791583 | Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T-lymphocyte subset in normal and mycosis fungoides skin. |
| Q44973310 | Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study |
| Q52548227 | Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. |
| Q90050594 | NK Cells Contribute to the Immune Risk Profile in Kidney Transplant Candidates |
| Q73207949 | New evidence for vascular disease in patients with early rheumatoid arthritis |
| Q42833030 | Novel anti-inflammatory effect of statins: reduction of CD4+CD28null T lymphocyte frequency in patients with unstable angina. |
| Q35655728 | Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation. |
| Q39053063 | Peripheral arterial disease in patients with systemic lupus erythematosus: a prospective controlled study |
| Q36152969 | Peripheral frequency of CD4+ CD28- cells in acute ischemic stroke: relationship with stroke subtype and severity markers |
| Q58778121 | Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes |
| Q38095369 | Polymorphonuclear neutrophils and instability of the atherosclerotic plaque: a causative role? |
| Q37968509 | Positron emission tomography in acute coronary syndromes |
| Q41010381 | Prognostic Value of Circulating Inflammatory Cells in Patients with Stable and Acute Coronary Artery Disease |
| Q94322915 | Protein Phosphatase 5 Contributes to the Overexpression of Epigenetically Regulated T-Lymphocyte Genes in Patients with Lupus |
| Q38774904 | Readapting the adaptive immune response - therapeutic strategies for atherosclerosis |
| Q42577777 | Regulatory T cells and Atherosclerosis |
| Q38620803 | Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential. |
| Q37607081 | Rejuvenating the immune system in rheumatoid arthritis |
| Q36139395 | Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans. |
| Q38918734 | Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans. |
| Q38794852 | Rheumatoid Arthritis Pharmacotherapies: Do They Have Anti-Atherosclerotic Activity? |
| Q37140079 | Rheumatoid arthritis and cardiovascular disease |
| Q43122483 | Rheumatoid arthritis and coronary atherosclerosis: two cousins engaging in a dangerous liaison |
| Q24812262 | Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study |
| Q34445660 | Risk stratification in non-ST segment elevation acute coronary syndromes with special focus on recent guidelines. |
| Q30315902 | Role of T-cells in myocardial infarction |
| Q37892982 | Role of unusual CD4+ CD28- T cells in acute coronary syndrome |
| Q45569404 | Rosuvastatin induces apoptosis in CD4+CD28null T cells in patients with acute coronary syndromes |
| Q36370648 | Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells |
| Q35638369 | Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis |
| Q36440077 | Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome |
| Q35889270 | Signal inhibition by the dual-specific phosphatase 4 impairs T cell-dependent B-cell responses with age. |
| Q51037774 | Silent myocardial ischemia may be related to inflammatory response. |
| Q36401840 | Skewed distribution of proinflammatory CD4+CD28null T cells in rheumatoid arthritis |
| Q36917429 | Systemic Transcriptional Alterations of Innate and Adaptive Immune Signaling Pathways in Atherosclerosis, Ischemia Stroke, and Myocardial Infarction |
| Q38531965 | Systemic inflammatory response following acute myocardial infarction |
| Q54664592 | T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis. |
| Q30252112 | T cell senescence and cardiovascular diseases |
| Q90590521 | T cell subsets and functions in atherosclerosis |
| Q36283482 | T cells and cytokines in atherogenesis. |
| Q37192834 | T cells in arteritis and atherosclerosis |
| Q37324840 | T cells in rheumatoid arthritis |
| Q58914607 | T lymphocyte autoreactivity in inflammatory mechanisms regulating atherosclerosis |
| Q26859971 | T-cell aging in rheumatoid arthritis |
| Q36227892 | TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque |
| Q26740179 | Targeting T cells to treat atherosclerosis: odyssey from bench to bedside |
| Q38170328 | Targeting inflammation: impact on atherothrombosis |
| Q35806766 | Telomere dysfunction, autoimmunity and aging. |
| Q34051060 | Telomeres and immunological diseases of aging |
| Q57524912 | Th1/Th2 Functional Imbalance After Acute Myocardial Infarction: Coronary Arterial Inflammation or Myocardial Inflammation |
| Q92277202 | The Effect of Statins on the Functionality of CD4+CD25+FOXP3+ Regulatory T-cells in Acute Coronary Syndrome: A Systematic Review and Meta-analysis of Randomised Controlled Trials in Asian Populations |
| Q34776884 | The IL-33/ST2 pathway: therapeutic target and novel biomarker |
| Q58045474 | The ageing immune system and its clinical implications |
| Q37167783 | The complex role of T-cell-based immunity in atherosclerosis |
| Q24804863 | The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis |
| Q58694765 | The host cellular immune response to cytomegalovirus targets the endothelium and is associated with increased arterial stiffness in ANCA-associated vasculitis |
| Q34164644 | The immune system in atherosclerosis |
| Q40067370 | The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease. |
| Q103806791 | The immunology of rheumatoid arthritis |
| Q27000370 | The influence of innate and adaptive immune responses on atherosclerosis |
| Q38550407 | The life (and death) of CD4+ CD28(null) T cells in inflammatory diseases |
| Q35714970 | The role of KIR2DL3/HLA-C*0802 in Brazilian patients with rheumatoid vasculitis |
| Q27000791 | The role of T and B cells in human atherosclerosis and atherothrombosis |
| Q37050929 | The role of the vascular dendritic cell network in atherosclerosis |
| Q28082856 | The story of CD4+ CD28- T cells revisited: solved or still ongoing? |
| Q36194796 | The ubiquitin-proteasome system--micro target for macro intervention? |
| Q28188901 | Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease |
| Q61946763 | Therapy with infliximab decreases the CD4+CD28? T cell compartment in peripheral blood in patients with rheumatoid arthritis |
| Q73807442 | Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis |
| Q33646347 | Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: a magnetic resonance imaging study |
| Q37421814 | Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis |
| Q35953268 | Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis |
| Q37541433 | Unusual CD4+CD28- T Cells and Their Pathogenic Role in Chronic Inflammatory Disorders |
| Q30837712 | Upregulation of TH/IL-17 Pathway-Related Genes in Human Coronary Endothelial Cells Stimulated with Serum of Patients with Acute Coronary Syndromes |
| Q57371300 | Vitamin D deficiency, CD4+CD28null cells and accelerated atherosclerosis in chronic kidney disease |
| Q26830206 | What is causing my arthritis, doctor? A glimpse beyond the usual suspects in the pathogenesis of rheumatoid arthritis |
| Q81499376 | [Cardiovascular manifestations in inflammatory rheumatic diseases] |
| Q81772556 | [Cardiovascular manifestations in rheumatoid arthritis] |
| Q73656227 | [Infection and atherosclerosis] |
| Q80106732 | [Inflammation in acute coronary syndromes: mechanisms and clinical implications] |
| Q54439198 | miR-146a in PBMCs modulates Th1 function in patients with acute coronary syndrome. |
Search more.